Aileron Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2017 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aileron Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2017 to Q3 2024.
  • Aileron Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2024 was 21.7M shares, a 377% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 21.7M +17.1M +377% Nov 12, 2024 10-Q 2024-11-14
Q2 2024 21.7M +17.1M +377% Aug 12, 2024 10-Q 2024-08-14
Q1 2024 17M +12.4M +274% Apr 12, 2024 10-K 2024-04-15
Q3 2023 4.54M -86.3M -95% Oct 11, 2023 10-Q 2023-10-13
Q2 2023 4.54M -86.3M -95% Aug 9, 2023 10-Q 2023-08-11
Q1 2023 4.54M -86M -95% Mar 16, 2023 10-K/A 2023-04-28
Q3 2022 90.8M +250K +0.28% Oct 28, 2022 10-Q 2022-11-01
Q2 2022 90.8M +270K +0.3% Aug 11, 2022 10-Q 2022-08-15
Q1 2022 90.6M +363K +0.4% Mar 25, 2022 10-K 2022-03-28
Q3 2021 90.6M +49.9M +123% Nov 9, 2021 10-Q 2021-11-12
Q2 2021 90.6M +51.3M +131% Aug 9, 2021 10-Q 2021-08-11
Q1 2021 90.2M +62.4M +224% Mar 19, 2021 10-K 2021-03-24
Q3 2020 40.7M +12.9M +46.3% Nov 11, 2020 10-Q 2020-11-12
Q2 2020 39.3M +11.5M +41.2% Aug 4, 2020 10-Q 2020-08-05
Q1 2020 27.8M +12.9M +87% Mar 20, 2020 10-K 2020-03-30
Q3 2019 27.8M +13.1M +88.6% Nov 5, 2019 10-Q 2019-11-07
Q2 2019 27.8M +13.1M +88.7% Aug 5, 2019 10-Q 2019-08-06
Q1 2019 14.9M +141K +0.96% Mar 26, 2019 10-K 2019-03-29
Q3 2018 14.7M +29.7K +0.2% Nov 1, 2018 10-Q 2018-11-07
Q2 2018 14.7M +22.6K +0.15% Aug 6, 2018 10-Q 2018-08-07
Q1 2018 14.7M Mar 26, 2018 10-K 2018-04-02
Q3 2017 14.7M Nov 9, 2017 10-Q 2017-11-09
Q2 2017 14.7M Aug 10, 2017 10-Q 2017-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.